Nxera Pharma Co., Ltd.

4565.T · JPX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents¥28,461¥32,997¥34,465¥32,268
Short-Term Investments¥0¥0¥0¥3,935
Receivables¥9,827¥8,789¥6,033¥6,695
Inventory¥9,632¥8,718¥8,767¥8,838
Other Curr. Assets¥3,407¥3,288¥3,934¥6,119
Total Curr. Assets¥51,327¥53,792¥53,199¥57,855
Property Plant & Equip (Net)¥6,595¥6,879¥7,097¥7,468
Goodwill¥25,869¥25,799¥25,514¥25,693
Intangibles¥49,940¥50,586¥51,085¥51,911
Long-Term Investments¥4,491¥3,628¥3,947¥4,518
Tax Assets¥5,933¥3,977¥4,818¥4,021
Other NC Assets¥23¥28¥29¥32
Total NC Assets¥92,851¥90,897¥92,490¥93,643
Other Assets¥0¥0¥0¥0
Total Assets¥144,178¥144,689¥145,689¥151,498
Liabilities
Payables¥4,976¥4,435¥4,055¥4,052
Short-Term Debt¥6,668¥6,676¥6,682¥5,798
Tax Payable¥0¥0¥0¥0
Deferred Revenue¥0¥0¥0¥3,141
Other Curr. Liab.¥3,818¥2,668¥3,360¥244
Total Curr. Liab.¥16,341¥14,870¥14,296¥15,632
LT Debt¥53,610¥54,983¥56,355¥57,727
Deferred Rev, NC¥0¥0¥0¥3,776
Deferred Tax Liab, NC¥815¥986¥1,082¥1,857
Other NC Liab.¥4,894¥4,925¥3,658¥505
Total NC Liab.¥62,181¥63,958¥64,322¥67,348
Other Liabilities¥0¥0¥0¥0
Cap. Leases¥0¥3,942¥4,111¥4,375
Total Liabilities¥78,522¥78,828¥78,618¥82,980
Equity
Pref Stock¥0¥0¥0¥0
Common Stock¥47,450¥47,450¥47,172¥47,172
Retained Earnings-¥11,130-¥9,458-¥21,702-¥20,942
AOCI¥7,739¥6,852¥6,143¥7,217
Other Equity¥0¥0¥0¥0
Total Equity¥65,656¥65,861¥67,071¥68,518
Supplemental Information
Minority Interest¥0¥0¥0¥0
Total Liab. & Tot. Equity¥144,178¥144,689¥145,689¥151,498
Net Debt¥31,817¥28,662¥28,572¥31,257
Nxera Pharma Co., Ltd. (4565.T) Financial Statements & Key Stats | AlphaPilot